Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer

PURPOSE: Abiraterone acetate (AA) is a standard of care for metastatic castration-resistant prostate cancer (CRPC). Despite a large food effect, AA was administered under fasting conditions in its pivotal trials. We sought to test the hypothesis that low-dose AA (LOW; 250 mg with a low-fat meal) wou...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Szmulewitz, Russell Z., Peer, Cody J., Ibraheem, Abiola, Martinez, Elia, Kozloff, Mark F., Carthon, Bradley, Harvey, R. Donald, Fishkin, Paul, Yong, Wei Peng, Chiong, Edmund, Nabhan, Chadi, Karrison, Theodore, Figg, William D., Stadler, Walter M., Ratain, Mark J.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2018
נושאים:
ORIGINAL REPORTS
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941614/
https://ncbi.nlm.nih.gov/pubmed/29590007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.76.4381
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים